Initial clinical characterization of novel proximal biomarkers for nx-1607, a first-inclass oral cbl-b inhibitor, in patients with advanced malignancies

Regular and Young Investigator Award Abstracts(2022)

Cited 0|Views22
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined